Fludarabine monophosphate reduces the incidence and severity of graft- versus-host disease in a murine model of bone marrow transplantation [1]

Blood

Volumn 90, Issue 1, 1997, Pages 471-

  Or, R ^a   Weiss, L ^a   Teiman, S ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FLUDARABINE PHOSPHATE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; GRAFT VERSUS HOST REACTION; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; T LYMPHOCYTE;

ANIMALS; BONE MARROW TRANSPLANTATION; GRAFT VS HOST DISEASE; IMMUNOSUPPRESSIVE AGENTS; MICE; TRANSPLANTATION, HOMOLOGOUS; VIDARABINE;

EID: 0030997673     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (13)